Logo image of LFMDP

LIFEMD INC - LFMD 8 7/8 PERP (LFMDP) Stock Fundamental Analysis

NASDAQ:LFMDP - US53216B2034

23.6465 USD
+0.29 (+1.23%)
Last: 9/4/2025, 2:35:56 PM
Fundamental Rating

3

Taking everything into account, LFMDP scores 3 out of 10 in our fundamental rating. LFMDP was compared to 35 industry peers in the Health Care Technology industry. Both the profitability and financial health of LFMDP have multiple concerns. While showing a medium growth rate, LFMDP is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

LFMDP had negative earnings in the past year.
LFMDP had a positive operating cash flow in the past year.
LFMDP had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: LFMDP reported negative operating cash flow in multiple years.
LFMDP Yearly Net Income VS EBIT VS OCF VS FCFLFMDP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

Looking at the Return On Assets, with a value of -12.28%, LFMDP is in line with its industry, outperforming 54.29% of the companies in the same industry.
Industry RankSector Rank
ROA -12.28%
ROE N/A
ROIC N/A
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LFMDP Yearly ROA, ROE, ROICLFMDP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K

1.3 Margins

LFMDP has a better Gross Margin (87.57%) than 91.43% of its industry peers.
LFMDP's Gross Margin has improved in the last couple of years.
LFMDP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 87.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
LFMDP Yearly Profit, Operating, Gross MarginsLFMDP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

3

2. Health

2.1 Basic Checks

LFMDP does not have a ROIC to compare to the WACC, probably because it is not profitable.
LFMDP has more shares outstanding than it did 1 year ago.
The number of shares outstanding for LFMDP has been increased compared to 5 years ago.
LFMDP has a better debt/assets ratio than last year.
LFMDP Yearly Shares OutstandingLFMDP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
LFMDP Yearly Total Debt VS Total AssetsLFMDP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 6.85 indicates that LFMDP is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.85, LFMDP belongs to the top of the industry, outperforming 82.86% of the companies in the same industry.
LFMDP has a debt to FCF ratio of 2.31. This is a good value and a sign of high solvency as LFMDP would need 2.31 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 2.31, LFMDP is doing good in the industry, outperforming 71.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.31
Altman-Z 6.85
ROIC/WACCN/A
WACC10.11%
LFMDP Yearly LT Debt VS Equity VS FCFLFMDP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

A Current Ratio of 0.77 indicates that LFMDP may have some problems paying its short term obligations.
The Current ratio of LFMDP (0.77) is worse than 80.00% of its industry peers.
LFMDP has a Quick Ratio of 0.77. This is a bad value and indicates that LFMDP is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.72, LFMDP is doing worse than 80.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.72
LFMDP Yearly Current Assets VS Current LiabilitesLFMDP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 70.00% over the past year.
LFMDP shows a strong growth in Revenue. In the last year, the Revenue has grown by 37.74%.
The Revenue has been growing by 76.23% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)70%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.42%
Revenue 1Y (TTM)37.74%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%22.81%

3.2 Future

LFMDP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42.40% yearly.
LFMDP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.29% yearly.
EPS Next Y86.4%
EPS Next 2Y57.71%
EPS Next 3Y42.4%
EPS Next 5YN/A
Revenue Next Year23.06%
Revenue Next 2Y20.2%
Revenue Next 3Y19.29%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LFMDP Yearly Revenue VS EstimatesLFMDP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
LFMDP Yearly EPS VS EstimatesLFMDP Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5 -2

2

4. Valuation

4.1 Price/Earnings Ratio

LFMDP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 89.86, the valuation of LFMDP can be described as expensive.
LFMDP's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.48. LFMDP is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 89.86
LFMDP Price Earnings VS Forward Price EarningsLFMDP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

LFMDP's Enterprise Value to EBITDA ratio is in line with the industry average.
LFMDP's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 158.96
EV/EBITDA 120.6
LFMDP Per share dataLFMDP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
LFMDP's earnings are expected to grow with 42.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y57.71%
EPS Next 3Y42.4%

4

5. Dividend

5.1 Amount

LFMDP has a Yearly Dividend Yield of 9.62%, which is a nice return.
LFMDP's Dividend Yield is rather good when compared to the industry average which is at 5.88. LFMDP pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, LFMDP pays a better dividend.
Industry RankSector Rank
Dividend Yield 9.62%

5.2 History

LFMDP has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
LFMDP Yearly Dividends per shareLFMDP Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

The earnings of LFMDP are negative and hence is the payout ratio. LFMDP will probably not be able to sustain this dividend level.
DP-34.38%
EPS Next 2Y57.71%
EPS Next 3Y42.4%
LFMDP Yearly Income VS Free CF VS DividendLFMDP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

LIFEMD INC - LFMD 8 7/8 PERP

NASDAQ:LFMDP (9/4/2025, 2:35:56 PM)

23.6465

+0.29 (+1.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners37.54%
Inst Owner ChangeN/A
Ins Owners17.39%
Ins Owner ChangeN/A
Market Cap1.07B
Analysts81.33
Price Target28.04 (18.58%)
Short Float %0%
Short Ratio0.38
Dividend
Industry RankSector Rank
Dividend Yield 9.62%
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP-34.38%
Div Incr Years0
Div Non Decr Years1
Ex-Date07-03 2025-07-03 (0.5546875)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-258.37%
Min EPS beat(2)-635.29%
Max EPS beat(2)118.55%
EPS beat(4)2
Avg EPS beat(4)-117.63%
Min EPS beat(4)-635.29%
Max EPS beat(4)118.55%
EPS beat(8)3
Avg EPS beat(8)-68.88%
EPS beat(12)5
Avg EPS beat(12)-64.04%
EPS beat(16)6
Avg EPS beat(16)-52.91%
Revenue beat(2)1
Avg Revenue beat(2)-2.54%
Min Revenue beat(2)-8.06%
Max Revenue beat(2)2.97%
Revenue beat(4)2
Avg Revenue beat(4)0.5%
Min Revenue beat(4)-8.06%
Max Revenue beat(4)9.78%
Revenue beat(8)5
Avg Revenue beat(8)1.81%
Revenue beat(12)7
Avg Revenue beat(12)-0.1%
Revenue beat(16)7
Avg Revenue beat(16)-1.47%
PT rev (1m)-7.21%
PT rev (3m)-30.07%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)-3456.64%
EPS NY rev (1m)-500%
EPS NY rev (3m)-176.92%
Revenue NQ rev (1m)-8.48%
Revenue NQ rev (3m)-5.72%
Revenue NY rev (1m)-6.39%
Revenue NY rev (3m)-6.27%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 89.86
P/S 4.34
P/FCF 158.96
P/OCF 54.68
P/B N/A
P/tB N/A
EV/EBITDA 120.6
EPS(TTM)-0.21
EYN/A
EPS(NY)0.26
Fwd EY1.11%
FCF(TTM)0.15
FCFY0.63%
OCF(TTM)0.43
OCFY1.83%
SpS5.45
BVpS-0.04
TBVpS-0.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.28%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 87.57%
FCFM 2.73%
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
F-Score5
Asset Turnover3.34
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.31
Debt/EBITDA 0.41
Cap/Depr 120.74%
Cap/Sales 5.2%
Interest Coverage N/A
Cash Conversion 227.76%
Profit Quality N/A
Current Ratio 0.77
Quick Ratio 0.72
Altman-Z 6.85
F-Score5
WACC10.11%
ROIC/WACCN/A
Cap/Depr(3y)162.46%
Cap/Depr(5y)195.18%
Cap/Sales(3y)6.18%
Cap/Sales(5y)4.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)70%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.42%
EPS Next Y86.4%
EPS Next 2Y57.71%
EPS Next 3Y42.4%
EPS Next 5YN/A
Revenue 1Y (TTM)37.74%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%22.81%
Revenue Next Year23.06%
Revenue Next 2Y20.2%
Revenue Next 3Y19.29%
Revenue Next 5YN/A
EBIT growth 1Y89.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year279.84%
EBIT Next 3Y73.97%
EBIT Next 5YN/A
FCF growth 1Y162.68%
FCF growth 3YN/A
FCF growth 5Y88.7%
OCF growth 1Y816.14%
OCF growth 3YN/A
OCF growth 5Y133.93%